Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche.
Louise M E MüllerGemma MignecoGina B ScottJenny DownSancha KingBasem AskarVictoria JenningsBabatunde OyajobiKaren J ScottEmma WestChristy RalphAdel SamsonElizabeth J IlettMunitta MuthanaMatt CoffeyAlan MelcherChristopher ParrishGordon CookMichelle LawsonFiona Errington-MaisPublished in: Journal for immunotherapy of cancer (2021)
These data highlight the importance of reovirus-induced immunotherapy for targeting MM cells within the BM niche and suggest that combination with agents which boost antitumor immune responses should be a priority.